This study evaluated the caries risk of asthmatic patients on the basis of mutans streptococci (MS) and lactobacilli levels in saliva samples as well as the index of oral hygiene and dental caries (DMFT index). The study population was composed of 80 asthmatic children, aged 3–15 years, who use specific medication, and 80 matched, healthy control children. The parents were interviewed about oral health-related factors. The World Health Organization criteria were used for dental examinations. The Köhler and Bratthal methodology was used to detect salivary MS levels and dilutions of saliva were done for lactobacilli counting. No differences between asthma and control groups were observed for caries prevalence in children aged 3–6 and 7–10 years, except in severe cases in the younger group. However, higher caries prevalence for permanent dentition was observed in 11- to 15-year-old asthmatic children. An increased dental biofilm was observed in the asthma group, as well as salivary levels of MS. No differences were observed in levels of lactobacilli. No statistical correlations were found between medication, frequency of treatment, method of consumption and caries experience, dental biofilm and salivary levels of MS or lactobacilli. However, there was a correlation between MS levels and treatment duration. The logistic regression revealed that MS level is an important risk factor for increased caries experience. Asthma should be evaluated as a risk factor for caries experience because it can increase the levels of MS and the dental biofilm.

1.
Anjomshoaa I, Cooper ME, Vieira AR: Caries is associated with asthma and epilepsy. Eur J Dent 2009;3:297–303.
2.
Beighton D: The complex oral microflora of high-risk individuals and groups and its role in the caries process. Community Dent Oral Epidemiol 2005;33:248–255.
3.
Eloot AK, Vanobbergen JN, De Baets F, Martens LC: Oral health and habits in children with asthma related to severity and duration of condition. Eur J Paediatr Dent 2004;5:210–215.
4.
Ersin NK, Gülen F, Eronat N, Cogulu D, Demir E, Tanaç R, Aydemir S: Oral and dental manifestations of young asthmatics related to medication, severity and duration of condition. Pediatr Int 2006;48:540–554.
5.
Gold O, Jordan HV, van Houte J: A selective medium for Streptococcus mutans. Arch Oral Biol 1973;18:1357–1364.
6.
Greene JC, Vermillion JR: The simplified oral hygiene index. J Am Dent Assoc 1964;68:7–13.
7.
Guergolette RP, Dezan CC, Frossard WT, Ferreira FB, Cerci Neto A, Fernandes KB: Prevalence of developmental defects of enamel in children and adolescents with asthma. J Bras Pneumol 2009;35:295–300.
8.
Kankaala TM, Virtanen JI, Larmas MA: Timing of first fillings in the primary dentition and permanent first molars of asthmatic children. Acta Odontol Scand 1998;56:20–24.
9.
Kenny DJ, Somaya P: Sugar load of oral liquid medications on chronically ill children. J Can Dent Assoc 1989;55:43–46.
10.
Köhler B, Bratthall D: Practical method to facilitate estimation of Streptococcus mutans levels in saliva. J Clin Microbiol 1979;9:584–588.
11.
Krasse B: Caries Risk: A Practical Guide for Assessment and Control. Chicago, Quintessence, 1988.
12.
Maguire A, Rugg-Gunn AJ, Butler TJ: Dental health of children taking antimicrobial and non-antimicrobial liquid oral medication long-term. Caries Res 1996;30:16–21.
13.
McDerra EJ, Pollard MA, Curzon ME: The dental status of asthmatic British school children. Pediatr Dent 1998;20:281–287.
14.
Mehta A, Sequeira PS, Sahoo RC: Bronchial asthma and dental caries risk: results from a case control study. J Contemp Dent Pract 2009;10:59–66.
15.
Meldrum AM, Thomson WM, Drummond BK, Sears MR: Is asthma a risk factor for dental caries? Findings from a cohort study. Caries Res 2001;35:235–239.
16.
Milano M, Lee JY, Donovan K, Chen JW: A cross-sectional study of medication-related factors and caries experience in asthmatic children. Pediatr Dent 2006;28:415–419.
17.
Paganini M, Dezan CC, Bichaco TR, de Andrade FB, Neto AC, Fernandes KB: Dental caries status and salivary properties of asthmatic children and adolescents. Int J Paediatr Dent 2011;21:185–191.
18.
Rang HP, Dale MM, Ritter JM, Moore PK: Pharmacology, ed 5. Edinburgh, Churchill Livingstone, 2003.
19.
Reddy DK, Hedge AM, Munshi AK: Dental caries status of children with bronchial asthma. J Clin Pediatr Dent 2003;27:293–296.
20.
Ryberg M, Möller C, Ericson T: Effect of β2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children. J Dent Res 1987;66:1404–1406.
21.
Ryberg M, Möller C, Ericson T: Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: a 4-year follow-up study. Scand J Dent Res 1991;99:212–218.
22.
Shashikiran ND, Reddy VVS, Raju PK: Effect of antiasthmatic medication on dental disease: dental caries and periodontal disease. J Indian Soc Pedod Prev Dent 2007;25:65–68.
23.
Shulman JD, Taylor SE, Nunn ME: The association between asthma and dental caries in children and adolescents: a population-based case-control study. Caries Res 2001;35:240–246.
24.
Stensson M, Wendt LK, Koch G, Nilsson M, Oldaeus G, Birkhed D: Oral health in pre-school children with asthma – followed from 3 to 6 years. Int J Paediatr Dent 2010;20:165–172.
25.
Watt RG: Strategies and approaches in oral disease prevention and health promotion. Bull World Health Organ 2005;83:711–718.
26.
Wogelius P, Poulsen S, Sørensen HT: Use of asthma-drugs and risk of dental caries among 5 to 7 year old Danish children: a cohort study. Community Dent Health 2004;21:207–211.
27.
World Health Organization: Oral Health Surveys – Basic Methods, ed 4. Geneva, World Health Organization, 1997.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.